0.637
0.31%
0.002
After Hours:
.64
0.003
+0.47%
Universe Pharmaceuticals Inc Stock (UPC) Forecast
The Universe Pharmaceuticals Inc (UPC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.7486, representing a +17.52% increase from the current price of $0.637. The highest analyst price target is $0.8969, and the lowest is $0.6004.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month UPC Price Target
Average 0.4497
(-29.41% Downside)
Is Universe Pharmaceuticals Inc (UPC) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 33.97 | Neutral |
STOCH(9,6) | 1.6649 | Buy |
STOCHRSI(14) | 42.32 | Neutral |
MACD(12,26) | -0.8321 | Buy |
ADX(14) | 14.75 | Neutral |
William %R | -99.38 | Buy |
CCI(14) | -59.62 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.8517
Sell
|
0.9281
Sell
|
MA20 |
1.3896
Sell
|
1.4309
Sell
|
MA50 |
3.1024
Sell
|
5.0721
Sell
|
MA100 |
17.39
Sell
|
13.00
Sell
|
MA200 |
27.45
Sell
|
19.80
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, UPC could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on UPC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.97 indicates that UPC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 1.6649 indicates that UPC is oversold. This indicates that UPC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.32 indicates that UPC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.75 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -59.62 indicates that UPC is still oversold but not to an extreme extent.
Long-term UPC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Universe Pharmaceuticals Inc financial reports and earnings history, Universe Pharmaceuticals Inc (UPC) stock could reach $1.9158 by 2030, $6.5406 by 2040 and $10.85 by 2050. See the projected annual prices until 2050 of the Universe Pharmaceuticals Inc stock below:
- Universe Pharmaceuticals Inc (UPC) is expected to reach an average price of $3.2374 in 2035, with a high prediction of $3.0274 and a low estimate of $1.9135. This indicates an $408.23% rise from the last recorded price of $0.637.
- Universe Pharmaceuticals Inc (UPC) stock is projected to chart a bullish course in 2040, with an average price target of $6.4387, representing an $910.79% surge from its current level. The forecast ranges from a conservative $6.4987 to a sky-high $6.5406.
- Our analysts predict Universe Pharmaceuticals Inc (UPC) to jump 792.62% by 2045, soaring from $5.6155 to an average price of $5.686, potentially reaching $5.5661. While $5.6155 is the low estimate, the potential upside is significant.
- Universe Pharmaceuticals Inc (UPC) stock is expected to climb by 2050, reaching an average of $10.89, a $1,609% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.85 and $10.92, respectively, highlighting the market's uncertainty.
Universe Pharmaceuticals Inc Stock (UPC) Year by Year Forecast
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2025
Universe Pharmaceuticals Inc Stock (UPC) is expected to reach an average price of $0.4497 in 2025, with a high prediction of $0.8969 and a low estimate of $0.00249. This indicates an -29.41% fall from the last recorded price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $0.6969 | $0.6004 | $0.8969 | +9.40% |
February, 2025 | $0.0834 | $0.00462 | $0.751 | -86.91% |
March, 2025 | $0.0699 | $0.00249 | $0.2197 | -89.03% |
April, 2025 | $0.0395 | $0.0259 | $0.204 | -93.80% |
May, 2025 | $0.2129 | $0.2253 | $0.1829 | -66.57% |
June, 2025 | $0.2412 | $0.2506 | $0.2188 | -62.13% |
July, 2025 | $0.2957 | $0.2923 | $0.2658 | -53.58% |
August, 2025 | $0.5492 | $0.3717 | $0.3093 | -13.79% |
September, 2025 | $0.5278 | $0.5069 | $0.4269 | -17.15% |
October, 2025 | $0.8248 | $0.8279 | $0.8121 | +29.49% |
November, 2025 | $0.7757 | $0.7956 | $0.808 | +21.78% |
December, 2025 | $0.845 | $0.8315 | $0.8491 | +32.65% |
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2026
The predicted value for Universe Pharmaceuticals Inc (UPC) in 2026 is set at an average of $0.8396. Estimates vary from a peak of $1.5856 to a trough of $0.0937, indicating an +31.81% surge from the present price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.6815 | $0.8067 | $0.7726 | +6.98% |
February, 2026 | $0.2769 | $0.3419 | $0.4343 | -56.52% |
March, 2026 | $0.1746 | $0.1554 | $0.2046 | -72.60% |
April, 2026 | $0.2853 | $0.1102 | $0.5428 | -55.21% |
May, 2026 | $0.4583 | $0.0937 | $0.7676 | -28.06% |
June, 2026 | $0.5718 | $0.4809 | $0.4359 | -10.24% |
July, 2026 | $0.6811 | $0.6675 | $0.6453 | +6.93% |
August, 2026 | $0.6946 | $0.6829 | $0.637 | +9.05% |
September, 2026 | $0.574 | $0.734 | $0.7064 | -9.89% |
October, 2026 | $0.5975 | $0.6357 | $0.5916 | -6.21% |
November, 2026 | $0.841 | $0.5833 | $0.736 | +32.02% |
December, 2026 | $0.9003 | $0.7697 | $1.5856 | +41.33% |
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Universe Pharmaceuticals Inc (UPC) is $4.2574, with a high forecast of $8.49 and a low forecast of $0.0248. This indicates an +568.35% increase from the last price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $0.2362 | $0.2362 | $1.1679 | -62.92% |
February, 2027 | $0.3207 | $0.2023 | $0.4386 | -49.65% |
March, 2027 | $0.3464 | $0.0322 | $0.9392 | -45.61% |
April, 2027 | $0.0201 | $0.0443 | $0.2475 | -96.84% |
May, 2027 | $0.1937 | $0.1519 | $0.3281 | -69.59% |
June, 2027 | $0.597 | $0.0512 | $0.9529 | -6.28% |
July, 2027 | $1.0335 | $0.6014 | $1.9353 | +62.25% |
August, 2027 | $0.61 | $0.0891 | $1.8877 | -4.23% |
September, 2027 | $0.9607 | $0.3507 | $1.1083 | +50.81% |
October, 2027 | $1.0672 | $0.5587 | $1.8389 | +67.54% |
November, 2027 | $0.51 | $0.45 | $8.49 | -19.94% |
December, 2027 | $0.2213 | $0.0248 | $3.7283 | -65.26% |
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2028
In 2028, Universe Pharmaceuticals Inc (UPC) is projected to reach an average price of $1.0019, with a high projection of $1.7376 and a low estimate of $0.2662. This indicates an +57.28% rise from the last price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $0.2157 | $0.2757 | $0.2095 | -66.14% |
February, 2028 | $0.3427 | $0.4409 | $0.2392 | -46.21% |
March, 2028 | $0.3114 | $0.2662 | $1.6486 | -51.12% |
April, 2028 | $1.0084 | $0.9166 | $0.7584 | +58.30% |
May, 2028 | $0.9571 | $1.0101 | $0.8718 | +50.25% |
June, 2028 | $0.7941 | $0.8723 | $0.8788 | +24.65% |
July, 2028 | $0.861 | $0.9337 | $0.8293 | +35.17% |
August, 2028 | $1.5197 | $0.9163 | $0.9697 | +138.58% |
September, 2028 | $1.5017 | $1.575 | $1.4367 | +135.75% |
October, 2028 | $1.7337 | $1.5818 | $1.5137 | +172.17% |
November, 2028 | $1.7324 | $1.6689 | $1.6454 | +171.96% |
December, 2028 | $1.7294 | $1.8059 | $1.7376 | +171.49% |
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2029
The 2029 price forecast for Universe Pharmaceuticals Inc Stock (UPC) is $1.6613 on average, with a high prediction of $2.2482 and a low estimate of $1.0744. This represents an +160.80% increase from the previous price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.8681 | $1.7611 | $1.7346 | +193.27% |
February, 2029 | $1.8651 | $1.8533 | $1.7516 | +192.79% |
March, 2029 | $1.9516 | $1.9663 | $1.8303 | +206.37% |
April, 2029 | $2.2614 | $1.9638 | $2.212 | +255.01% |
May, 2029 | $2.2134 | $2.2527 | $2.2443 | +247.48% |
June, 2029 | $2.2494 | $2.2112 | $2.2147 | +253.13% |
July, 2029 | $2.1418 | $2.2517 | $2.2482 | +236.23% |
August, 2029 | $1.7298 | $1.8904 | $2.1552 | +171.56% |
September, 2029 | $1.4374 | $1.6074 | $1.6546 | +125.65% |
October, 2029 | $1.0661 | $1.0744 | $1.2391 | +67.36% |
November, 2029 | $0.9467 | $1.1913 | $0.9613 | +48.62% |
December, 2029 | $1.7502 | $1.7209 | $1.7283 | +174.75% |
Universe Pharmaceuticals Inc Stock (UPC) Price Forecast for 2030
Universe Pharmaceuticals Inc Stock (UPC) is expected to reach an average price of $1.2096 in 2030, with a high forecast of $2.0086 and a low forecast of $0.4106. This signifies an +89.90% surge from the last price of $0.637.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $1.9587 | $1.7768 | $1.9158 | +207.48% |
February, 2030 | $1.9457 | $1.9457 | $1.9205 | +205.45% |
March, 2030 | $1.9827 | $1.9475 | $1.9527 | +211.26% |
April, 2030 | $1.7898 | $1.8877 | $1.9358 | +180.97% |
May, 2030 | $1.8984 | $1.7967 | $1.8132 | +198.02% |
June, 2030 | $2.0165 | $1.9692 | $2.0086 | +216.56% |
July, 2030 | $0.7735 | $0.4106 | $2.0021 | +21.43% |
August, 2030 | $0.8411 | $0.8858 | $0.8126 | +32.04% |
September, 2030 | $1.3281 | $0.9046 | $1.0256 | +108.49% |
October, 2030 | $1.1168 | $1.1868 | $1.0833 | +75.32% |
November, 2030 | $1.1637 | $1.1585 | $1.1421 | +82.69% |
December, 2030 | $0.7107 | $0.8207 | $1.2225 | +11.57% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):